HomeNewsBusinessStartupSwiggy suspends ‘Super’ subscription programme

Swiggy suspends ‘Super’ subscription programme

The decision comes at a time when rival Zomato has doubled down on its Gold programme.

May 12, 2020 / 12:28 IST
Story continues below Advertisement

Online food delivery platform Swiggy has indefinitely suspended its subscription service Super that was aimed at retaining customers and rewarding loyalty, sources said, as the coronavirus and lockdown continues to take a toll on business.

Current Swiggy Super subscribers can avail the service but new subscriptions and renewals have been withdrawn. An attempt to renew the membership leads to a page that says, “We ran out of subscriptions, will be back with more soon”.

Story continues below Advertisement

“The programme stands suspended as of now. Internally there is no clarity yet when it will be brought back, if at all, or if the company will move into any other form of membership product,” said a source. The person spoke on condition of anonymity as he is not authorised to speak to the media.

Swiggy did not respond to Moneycontrol’s queries on the reasons for the move.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show